Journal for ImmunoTherapy of Cancer (Nov 2020)
574 ONM-400, a novel approach for interleukin-2 therapy using a ph-activated nanoparticle targeting metabolic acidosis in solid cancers
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)